Y0002225

Regorafenib for FP system suitability

CRS, European Pharmacopoeia (EP) Reference Standard

• Sinónimos: Regorafenib monohydrate, 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide monohydrate
• Fórmula empírica (notación de Hill): C₂₁H₁₅ClF₄N₄O₃ · H₂O
• Número de CAS: 1019206-88-2
• Peso molecular: 500.83
• UNSPSC Code: 41116107
• NACRES: NA.24

Propiedades

• API family: regorafenib
• manufacturer/tradename: EDQM
• storage temp.: 2-8°C
• InChI: 1S/C21H15ClF4N4O3.H2O/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26;/h2-10H,1H3,(H,27,31)(H2,29,30,32);1H2
• InChI key: ZOPOQLDXFHBOIH-UHFFFAOYSA-N

Descripción

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Regorafenib for FP system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Información de seguridad

• pictograms: GHS08,GHS09
• signalword: Warning
• hcodes: H361fd,H373,H410
• pcodes: P201 - P202 - P260 - P273 - P280 - P308 + P313
• Hazard Classifications: Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 2 - STOT RE 2
• target_organs: Liver
• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable